HealthTech

New CMO Dietmar Berger highlights Gilead’s ‘unique situ...

Dietmar Berger said Gilead is in a “unique situation” as he assumes the role of ...

Human-Generated Aata: The Missing Link in AI-Powered Re...

Mounting financial pressures for healthcare organizations mean sustainability hi...

SpringWorks lands FDA approval for nerve tumor treatment

SpringWorks Therapeutics, a biotech potentially on the verge of being acquired, ...

ŌURA Secures $200 Million in Series D Funding

Investments from Fidelity Management & Research Company and Dexcom Bring ŌURA Va...

AI Scribes Have Proven Their Value — Where Do They Go f...

AI-powered documentation tools have proven successful in alleviating clinicians’...

Senators Introduce Bill that would Add Work Requirement...

Senators John Kennedy (R-Louisiana) and Eric Schmitt (R-Missouri) introduced a b...

41% of Third-Party Breaches in 2024 Targeted Healthcare...

What You Should Know:  – The healthcare industry continues to be the most heavil...

Intelerad and Strategic Radiology Partnership Drives In...

What You Should Know:  – Intelerad, a global leader in medical imaging software ...

Medidata Integrates UK Costing Data into Grants Manager...

What You Should Know:  – Medidata, a Dassault Systèmes brand and a leading provi...

AdventHealth Partners with Aidin to Enhance Care Coordi...

What You Should Know:  – AdventHealth, a healthcare system with over 50 hospital...

First Stop Health Appoints Vijay Anand as CTO and Willi...

What You Should Know:  – First Stop Health, a provider of on-demand virtual care...

Harrison.ai Secures $112M to Expand AI-Powered Medical ...

What You Should Know:  – Harrison.ai, a global healthtech company, today announc...

Drive Health Appoints Alexander Sicular as Chief Techno...

What You Should Know:  – Drive Health, a digital health startup revolutionizing ...

Aledade Adds 500 New Primary Care Practices to Value-Ba...

What You Should Know:  – Aledade, the nation’s largest network of independent pr...

Travere plans to seek expanded label for kidney drug

Travere Therapeutics said Tuesday it plans to ask the FDA for approval of its ki...

Biohaven gets FDA priority review for neuro disease dru...

Biohaven's experimental drug troriluzole for the rare, neurodegenerative disease...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.